News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Thyroid Cancer
February 2, 2019
The CancerConnect Thyroid Cancer Newsletter
Charles H. Weaver, MD
January 1, 2019
It’s National Thyroid Awareness Month
Charles H. Weaver, MD
December 8, 2018
Caprelsa Delays Progression of Advanced Medullary Thyroid Cancer
Charles H. Weaver, MD
August 17, 2018
Larotrectinib Demonstrates High Response Rate in TRK Thyroid Cancers
Charles H. Weaver, MD
August 2, 2018
FDA Approves Tafinlar plus Mekinst for Patients With Anaplastic Thyroid Cancer
Charles H. Weaver, MD
July 26, 2018
BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer
Charles H. Weaver, MD
July 25, 2018
Use of Radioactive Iodine for Thyroid Cancer Has Increased
Charles H. Weaver, MD
July 19, 2018
Gene Expression Test Identifies Low-Risk Thyroid Nodules
Charles H. Weaver, MD
July 18, 2018
Therapies Show Initial Effectiveness in Subset of Papillary Thyroid Cancer
Charles H. Weaver, MD
July 18, 2018
TSH Suppression after Thyroidectomy May Not Be Beneficial
Charles H. Weaver, MD
July 17, 2018
Lower Thyroid Stimulating Hormone Levels Elevate Risk of Thyroid Cancer
Charles H. Weaver, MD
July 13, 2018
Nexavar Approved for Metastatic Differentiated Thyroid Cancer
Charles H. Weaver, MD
Previous Page
1
2
3
4
5
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website